1,360 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Purchased by Wipfli Financial Advisors LLC

Wipfli Financial Advisors LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSICGet Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,360 shares of the company’s stock, valued at approximately $89,000.

Several other institutional investors also recently bought and sold shares of HSIC. Vanguard Group Inc. boosted its holdings in shares of Henry Schein by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 15,331,533 shares of the company’s stock worth $1,336,756,000 after purchasing an additional 214,846 shares during the last quarter. Pendal Group Ltd boosted its holdings in shares of Henry Schein by 26.0% during the 3rd quarter. Pendal Group Ltd now owns 4,414,378 shares of the company’s stock worth $290,334,000 after purchasing an additional 910,179 shares during the last quarter. Macquarie Group Ltd. boosted its holdings in shares of Henry Schein by 0.6% during the 2nd quarter. Macquarie Group Ltd. now owns 2,256,082 shares of the company’s stock worth $173,427,000 after purchasing an additional 12,378 shares during the last quarter. FMR LLC boosted its holdings in shares of Henry Schein by 189.6% during the 2nd quarter. FMR LLC now owns 2,179,126 shares of the company’s stock worth $167,226,000 after purchasing an additional 1,426,767 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new position in shares of Henry Schein during the 2nd quarter worth approximately $159,204,000. 95.45% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Up 0.8 %

Shares of NASDAQ HSIC opened at $80.62 on Thursday. The firm has a market cap of $10.93 billion, a price-to-earnings ratio of 17.53, a PEG ratio of 2.18 and a beta of 0.82. The company has a quick ratio of 1.00, a current ratio of 1.84 and a debt-to-equity ratio of 0.22. Henry Schein, Inc. has a 52-week low of $64.75 and a 52-week high of $92.68. The business’s 50 day moving average is $79.85 and its two-hundred day moving average is $75.43.

Henry Schein (NASDAQ:HSICGet Rating) last announced its earnings results on Tuesday, November 1st. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.01. The company had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 15.48% and a net margin of 5.06%. Research analysts predict that Henry Schein, Inc. will post 4.81 EPS for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent research reports. Morgan Stanley lowered their target price on Henry Schein from $72.00 to $70.00 and set an “underweight” rating on the stock in a report on Wednesday, December 21st. William Blair reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Tuesday, November 1st. Piper Sandler reduced their price target on shares of Henry Schein from $96.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, September 26th. Finally, StockNews.com raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $84.44.

Insider Buying and Selling at Henry Schein

In other news, CEO Stanley M. Bergman sold 54,216 shares of the company’s stock in a transaction on Monday, December 12th. The stock was sold at an average price of $81.16, for a total transaction of $4,400,170.56. Following the sale, the chief executive officer now owns 488,126 shares of the company’s stock, valued at $39,616,306.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Bradford C. Connett sold 6,840 shares of the company’s stock in a transaction on Wednesday, December 21st. The stock was sold at an average price of $80.71, for a total transaction of $552,056.40. Following the sale, the chief executive officer now owns 55,412 shares of the company’s stock, valued at $4,472,302.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stanley M. Bergman sold 54,216 shares of the company’s stock in a transaction on Monday, December 12th. The stock was sold at an average price of $81.16, for a total value of $4,400,170.56. Following the sale, the chief executive officer now directly owns 488,126 shares in the company, valued at approximately $39,616,306.16. The disclosure for this sale can be found here. Insiders have sold a total of 76,397 shares of company stock valued at $6,190,246 over the last quarter. 1.00% of the stock is owned by company insiders.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICGet Rating).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.